Evidence map›Paper›PMID 36005249›Full record

ReviewDentistry journal2022

Success Rates of Zygomatic Implants for the Rehabilitation of Severely Atrophic Maxilla: A Systematic Review.

Aleix Solà Pérez, David Pastorino, Carlos Aparicio, Marta Pegueroles Neyra, Rabia Sannam Khan, Simon Wright, Cemal Ucer

Abstract readReview
In one paragraph

Review in Dentistry journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Assessment of different treatment alternatives for patients with total maxillectomy.Journal of prosthodontics : official journal of the American College of Prosthodontists · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Aleix Solà PérezZygoma ZAGA Centers, Carrer Castellá 33, 08018 Barcelona, Spain.
David PastorinoZygoma ZAGA Centers, Carrer Castellá 33, 08018 Barcelona, Spain.
Carlos AparicioZygoma ZAGA Centers, Carrer Castellá 33, 08018 Barcelona, Spain.ORCID 0000-0002-2069-691X
Marta Pegueroles NeyraBiomaterials, Biomechanics and Tissue Engineering Group, Department of Materials Science and Engineering, Universitat Politècnica de Catalunya (UPC), EEBE, 08019 Barcelona, Spain.ORCID 0000-0002-7895-8337
Rabia Sannam KhanICE Postgraduate Dental Institute and Hospital, Salford M50 3XZ, UK.ORCID 0000-0001-7421-5248
Simon WrightICE Postgraduate Dental Institute and Hospital, Salford M50 3XZ, UK.
Cemal UcerICE Postgraduate Dental Institute and Hospital, Salford M50 3XZ, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Zygomatic implants are a treatment solution for patients with severe maxillary atrophy. This treatment option allows delivering immediate fixed teeth within 24 h. Numerous peer-reviewed publications have reported different success rates, resulting in a disagreement on the topic. Therefore, the overall efficacy and predictability of this rehabilitation is still a matter of discussion. With this study, we aimed to identify the published literature on the use of zygomatic implants for the reconstruction of the severely atrophic maxilla and report the cumulative success rate (CSR) as a function of follow-up time. A systematic review of the literature on zygomatic implant for the treatment of severe maxillary atrophy was performed and 196 publications were included in the study. The cumulative success rate of zygomatic implants for the treatment of severe maxillary atrophy was 98.5% at less than 1 year, 97.5% between 1 and 3 years, 96.8% between 3 and 5 years and 96.1% after more than 5 years. The most commonly reported complications were soft tissue dehiscence, rhinosinusitis and prosthetic failures. The treatment of severe lack of bone in the upper maxilla with zygomatic implants is a safe procedure, reaching a cumulative success rate of 96.1% after more than 5 years.

Indexed as

atrophic maxillacumulative success ratedental implantszygomatic implants

Identifiers

PMID36005249
PMCPMC9406716

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.